Levodopa and executive performance in Parkinson's disease: a randomized study.

scientific article published in September 2008

Levodopa and executive performance in Parkinson's disease: a randomized study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S1355617708081010
P698PubMed publication ID18764978

P50authorIgnasi GichQ50617525
Antonia CampolongoQ57015573
Jaime KulisevskyQ64855171
Javier PagonabarragaQ64855172
Berta Pascual-SedanoQ66717789
Alexandre GironellQ42408233
P2093author name stringManel Barbanoj
Carmen García-Sánchez
P2860cites work“Mini-mental state”Q25938989
An Inventory for Measuring DepressionQ26778503
High-Speed Scanning in Human MemoryQ28257618
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 casesQ29614910
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's diseaseQ31027552
Dopamine supports sentence comprehension in Parkinson's DiseaseQ32145067
Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction.Q33889084
Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levelsQ48839986
The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's diseaseQ48891136
Neuropsychological profile of patients with Parkinson's disease without dementia.Q51950566
Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.Q52027275
Age-related cognitive deficits mediated by changes in the striatal dopamine system.Q52028033
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.Q52051956
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.Q52170683
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's diseaseQ62706215
D(1) receptors in prefrontal cells and circuitsQ73553186
Nonmotor fluctuations in Parkinson's disease: frequent and disablingQ74606841
Shared cognitive processes underlying performance on the Wisconsin Card Sorting Test and the Stroop Test in patients with schizophrenia: a measurement artifact?Q79214181
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's diseaseQ33985023
Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonismQ34070904
Neural bases of set-shifting deficits in Parkinson's disease.Q34291524
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's diseaseQ34423750
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidateQ34753882
L-dopa impairs learning, but spares generalization, in Parkinson's diseaseQ35113281
What contributes to quality of life in patients with Parkinson's disease?Q35459164
What causes mental dysfunction in Parkinson's disease?Q35540203
Levodopa in the treatment of Parkinson's disease: current controversiesQ35889917
Molecular imaging of the dopaminergic system and its association with human cognitive functionQ36472025
Cognitive function in Parkinson's disease: From description to theoryQ36555846
Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?Q36587747
Insights into the role of dopamine receptor systems in learning and memoryQ36778973
Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian ratsQ36969324
Basal ganglia dysfunction, working memory, and sentence comprehension in patients with Parkinson's diseaseQ38438683
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-upQ39216879
Clinical applications of visual analogue scales: a critical review.Q39583550
Issues associated with repeated neuropsychological assessmentsQ40973194
The response to levodopa in Parkinson's disease: imposing pharmacological law and orderQ40981288
Pathogenesis of dyskinesias in Parkinson's diseaseQ41233549
'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopaQ41437567
Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflowQ41476240
Dopaminergic modulation of cortical function in patients with Parkinson's diseaseQ42163888
Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's diseaseQ42603205
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunctionQ43643543
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demandsQ43800068
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.Q43901509
A model of prefrontal cortex dopaminergic modulation during the delayed alternation taskQ44111114
Dopaminergic modulation of visual-spatial working memory in Parkinson's diseaseQ44302201
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's diseaseQ44505615
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesiasQ45030408
By carrot or by stick: cognitive reinforcement learning in parkinsonismQ45140702
Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS-R NI.Q46308362
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implicationsQ48088787
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's diseaseQ48147372
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunctionQ48176523
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memoryQ48285410
Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunctionQ48320111
The neural correlates and functional integration of cognitive control in a Stroop taskQ48505681
Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET studyQ48508628
High-speed memory scanning in Parkinson's disease: adverse effects of levodopaQ48713181
Cognitive deficits in the early stages of Parkinson's diseaseQ48800336
P433issue5
P921main subjectParkinson's diseaseQ11085
levodopaQ300989
P304page(s)832-841
P577publication date2008-09-01
P1433published inJournal of the International Neuropsychological SocietyQ15755321
P1476titleLevodopa and executive performance in Parkinson's disease: a randomized study.
P478volume14

Reverse relations

cites work (P2860)
Q40099576A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's Disease.
Q38156172Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review
Q44784228Apathy in Parkinson's disease: more than just executive dysfunction
Q37968511Cognitive impairment in nondemented Parkinson's disease
Q42515523Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease
Q43285160Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances
Q21090466Executive dysfunction in Parkinson's disease and timing deficits
Q38134409Executive dysfunction in Parkinson's disease: a review
Q48275756Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders
Q37141684Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease
Q38805976Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease
Q38111335Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease
Q39601396Startle Habituation and Midfrontal Theta Activity in Parkinson Disease.
Q27021220Mild cognitive impairment in Parkinson's disease.

Search more.